Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits
There is a renewed interest on the reliance of food-based bioactive compounds as sources of nutritive factors and health-beneficial chemical compounds. Among these food components, several proteins from foods have been shown to promote health and wellness as seen in proteins such as α/γ-conglutins from the seeds of <i<Lupinus</i< species (Lupin)<i<,</i< a genus of leguminous plant that are widely used in traditional medicine for treating chronic diseases. Lupin-derived peptides (LDPs) are increasingly being explored and they have been shown to possess multifunctional health improving properties. This paper discusses the intestinal transport, bioavailability and biological activities of LDPs, focusing on molecular mechanisms of action as reported in in vitro, cell culture, animal and human studies. The potentials of several LDPs to demonstrate multitarget mechanism of regulation of glucose and lipid metabolism, chemo- and osteoprotective properties, and antioxidant and anti-inflammatory activities position LDPs as good candidates for nutraceutical development for the prevention and management of medical conditions whose etiology are multifactorial..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Nutrients - 13(2021), 9, p 3266 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Innocent U. Okagu [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|
|---|
| doi: |
10.3390/nu13093266 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ058561110 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ058561110 | ||
| 003 | DE-627 | ||
| 005 | 20240412141812.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/nu13093266 |2 doi | |
| 035 | |a (DE-627)DOAJ058561110 | ||
| 035 | |a (DE-599)DOAJ9df17e787b71459d914eea2843bcf729 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a TX341-641 | |
| 100 | 0 | |a Innocent U. Okagu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a There is a renewed interest on the reliance of food-based bioactive compounds as sources of nutritive factors and health-beneficial chemical compounds. Among these food components, several proteins from foods have been shown to promote health and wellness as seen in proteins such as α/γ-conglutins from the seeds of <i<Lupinus</i< species (Lupin)<i<,</i< a genus of leguminous plant that are widely used in traditional medicine for treating chronic diseases. Lupin-derived peptides (LDPs) are increasingly being explored and they have been shown to possess multifunctional health improving properties. This paper discusses the intestinal transport, bioavailability and biological activities of LDPs, focusing on molecular mechanisms of action as reported in in vitro, cell culture, animal and human studies. The potentials of several LDPs to demonstrate multitarget mechanism of regulation of glucose and lipid metabolism, chemo- and osteoprotective properties, and antioxidant and anti-inflammatory activities position LDPs as good candidates for nutraceutical development for the prevention and management of medical conditions whose etiology are multifactorial. | ||
| 650 | 4 | |a lupin | |
| 650 | 4 | |a <i<Lupinus species</i< | |
| 650 | 4 | |a lupin protein hydrolysates | |
| 650 | 4 | |a lupin-derived peptides | |
| 650 | 4 | |a functional foods | |
| 650 | 4 | |a bioactive peptides | |
| 653 | 0 | |a Nutrition. Foods and food supply | |
| 700 | 0 | |a Joseph C. Ndefo |e verfasserin |4 aut | |
| 700 | 0 | |a Emmanuel C. Aham |e verfasserin |4 aut | |
| 700 | 0 | |a Joy I. Obeme-Nmom |e verfasserin |4 aut | |
| 700 | 0 | |a Precious E. Agboinghale |e verfasserin |4 aut | |
| 700 | 0 | |a Rita N. Aguchem |e verfasserin |4 aut | |
| 700 | 0 | |a Regina N. Nechi |e verfasserin |4 aut | |
| 700 | 0 | |a Carmen Lammi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Nutrients |d MDPI AG, 2009 |g 13(2021), 9, p 3266 |w (DE-627)DOAJ000071234 |x 20726643 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:9, p 3266 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/nu13093266 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9df17e787b71459d914eea2843bcf729 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6643/13/9/3266 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2072-6643 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2021 |e 9, p 3266 | ||